CREDIT SUISSE AG/ - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 12 filers reported holding CLOVIS ONCOLOGY INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q2 2019$789,000
-88.7%
890,000
-88.1%
0.00%
-83.3%
Q3 2018$7,003,000
-63.3%
7,500,000
-57.7%
0.01%
-68.4%
Q2 2018$19,058,000
+50.4%
17,727,000
+62.0%
0.02%
+58.3%
Q1 2018$12,672,000
+5.3%
10,942,000
+22.4%
0.01%
+9.1%
Q4 2017$12,031,000
-42.9%
8,941,000
-34.6%
0.01%
-45.0%
Q3 2017$21,077,000
-21.2%
13,675,000
-13.4%
0.02%
-23.1%
Q2 2017$26,733,000
+144.0%
15,795,000
+85.6%
0.03%
+160.0%
Q1 2017$10,957,000
+27.5%
8,510,000
+1.7%
0.01%
+11.1%
Q4 2016$8,594,000
-17.8%
8,364,000
-24.4%
0.01%
-10.0%
Q3 2016$10,454,000
+22.6%
11,062,000
+5574.5%
0.01%
+11.1%
Q2 2016$8,526,000194,9410.01%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q3 2019
NameSharesValueWeighting ↓
Antara Capital LP 47,807,000$42,639,0009.29%
MRCap LP 26,445,000$23,587,0004.58%
SYMPHONY ASSET MANAGEMENT LLC 15,500,000$13,786,0002.88%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 18,000,000$15,902,0000.57%
TENOR CAPITAL MANAGEMENT Co., L.P. 11,000,000$9,894,0000.50%
ADVENT CAPITAL MANAGEMENT /DE/ 24,758,000$22,019,0000.43%
Graham Capital Management, L.P. 14,700,000$13,047,0000.38%
WESTWOOD HOLDINGS GROUP INC 21,000,000$18,729,0000.20%
OAKTREE CAPITAL MANAGEMENT LP 6,315,000$5,634,0000.11%
AQR Arbitrage LLC 10,000,000$8,919,0000.10%
View complete list of CLOVIS ONCOLOGY INC shareholders